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ABSTRACT
Objective: To describe a community-based HIV
testing programme.
Design and setting: An intervention of HIV voluntary
testing conducted in non-medical settings in four
French cities.
Participants: Men who have sex with men (MSM).
Intervention: Counselling and rapid HIV testing
staffed by trained personnel from an HIV/AIDS
community-based organisation.
Primary and secondary outcome measures: The
population that has taken hold of the intervention and
the satisfaction of participants. Data were collected on
demographics, HIV testing history, sexual practices
and satisfaction with the testing programme.
Results: 532 MSM were tested between February 2009
and June 2010, of whom 49 (9%) were tested two or
more times. 468 MSM (88%) had casual male partners
in the previous 6 months, and 152 (35%) reported
having unprotected anal intercourse with risky casual
partners (HIV infected or HIV serostatus unknown). 159
men (30%) had not been tested in the previous 2 years,
and 50 (31%) of whom had unprotected anal
intercourse with risky casual partners. Among the 15
patients who tested positive (2.8%), 12 (80%) received
conﬁrmation and were linked to care (median CD4 cell
count ¼550/mm
3). Satisfaction was high: 92% reported
being ‘very satisﬁed’ with their experience. Steps of
counselling and testing procedure were respected by
testers and difﬁculties in handling tests were rare.
Conclusions: This community-based HIV testing
programme reached high-risk MSM, of whom
a substantial proportion had not been tested lately.
This novel service supplements pre-existing HIV
testing services and increases access to HIV testing in
high-risk groups.
INTRODUCTION
Until very recently in France, only physicians
could prescribe, perform and provide the
results of HIV tests. Although current HIV
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ARTICLE SUMMARY
Article focus
- How extend testing facilities to reach and test for
HIV more MSM and diagnose HIV-infected MSM
earlier?
- The presence of peers and non-clinical staff
members who address sexuality more openly
and avoid medical jargon during counselling
sessions could offset cultural barriers and reduce
fears of HIV and associated stigma.
- The article describes an experimental
programme of community-based HIV testing:
the population reached, the quality of the
programme and the satisfaction of participants.
Key messages
- This community-based HIV testing and counsel-
ling programme reaches MSM with high-risk
sexual behaviour, a substantial proportion of
whom has not tested for HIV recently.
- Community testers are able to perform rapid HIV
test into a comprehensive prevention approach in
line with participant’s life.
- 2.8% of participants tested positive. Infection
was conﬁrmed in all cases, 80% were linked to
care. Cases were diagnosed at early stages of
disease.
Strengths and limitations of this study
- This HIV testing and counselling programme is
exclusively based on MSM community, and
continuing the prevention counselling with the
awareness of the HIV serostatus includes testing
into a comprehensive prevention approach.
- Community-based HIV testing programmes may
be attractive and efﬁcient in large urban areas
(like Paris), but perhaps less so in smaller cities,
where an outreach approach may work better.
- The number of HIV diagnoses was small; the
prevalence and median CD4 count among the
few HIV-infected participants should therefore be
interpreted with caution.
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Open Access Researchtesting rates in France rank second in Europe,
1 roughly
50000 of an estimated 135000e170000 people infected
with HIV remain unaware of their infection.
2 Among
people the most concerned by HIV, men who have sex
with men (MSM) account for half of new HIV infections
approximately.
34The HIV incidence in MSM is 60-fold
higher than in the overall population.
3 Moreover,
a recent study demonstrated that 32% of MSM were
diagnosed at advanced stages of disease.
5
The most signiﬁcant barrier to early HIV testing is the
absence of perception of risk for HIV.
6e8 In an effort to
overcome this barrier, the French ministry of health
recently recommended that physicians perform one-
time routine voluntary HIV tests in the general popula-
tion and annually in population groups at high risk of
infection such as MSM.
91 0However, barriers to HIV
testing remain at the individual level: fear of the disease,
its disclosure and subsequent social stigma, as well as
poor access to HIV testing.
6e8 In addition, the gay
community highlight inappropriate counselling and
some moralistic attitudes face to their sexual practices
and testing habits in conventional testing services as
barriers to regular HIV testing.
11
The recent availability and acceptability of rapid HIV
tests
12 13 offer an opportunity to implement new HIV
testing strategies. A community-based HIV screening
programme, for instance, may increase access in some
populations by offering a more attractive and convenient
location than doctor’s ofﬁces. The presence of peers
and non-clinical staff members who address sexuality
more openly and avoid medical jargon during counsel-
ling sessions could also offset cultural barriers
and reduce fears of HIV and associated stigma.
Furthermore, some community-based organisations
(CBOs) have been engaged in outreach prevention in
which sexual practices, HIV exposures and testing
are addressed. Continuing the prevention counselling
with the awareness of the HIV serostatus could include
testing in a comprehensive strategy of HIV exposure
reduction.
In recent years, several European countries
14e18 have
begun implementing community-based HIV testing with
rapid tests. They propose rapid testing in CBOs in large
urban areas. The principle behind this strategy is the
same than the one applied in developing countries
where testing is conducted by lay counsellors from the
community to facilitate access to testing to vulnerable
populations.
19 However, most of the reported
programmes in developed countries involve medical
staff, and although welcoming and support are
conducted by community peers, HIV tests are performed
by healthcare workers. To our knowledge, in Europe, the
only ongoing community-based HIV testing programmes
that do not involve medical staff is Checkpoint in
Barcelona, Spain,
20 and LASS in Leicester, England
(http://www.lass.org.uk). However, data on these
programmes (evaluation of an existing programme or
set up into a study) have not yet been published.
The hypothesis was that a community-based HIV
testing intervention may reach high-risk MSM, a high
proportion of whom have not been tested lately; conse-
quently, in addition to other existing HIV testing
services, it may increase access to HIV testing in high-risk
groups. The ANRSeCOM’TEST Study describes
a community-based HIV testing and counselling
programme performed by peers in non-medical settings
that targeted MSM. The purposes were to describe
characteristics of the MSM who has taken hold of this
programme and the satisfaction of participating MSM.
METHODS
Ethics statement
ANRSeCOM’TEST Study was approved by the French
Comite ´ de protection des personnes Nord-Ouest III and
the Agence franc ¸aise de se ´curite ´ sanitaire des produits
de sante ´. All participants were informed of the study and
had to sign a consent form to be included. The survey
was anonymous.
Intervention
The community-based HIV testing was managed by
AIDES, a French CBO that focuses on outreach and
prevention among exposed population and notably
MSM. Although not being healthcare workers, trained
AIDES CBO staff members performed the whole testing
procedure including pre- and post-test counselling,
rapid HIV tests as well as delivery of test result (ﬁgure 1).
Prior to HIV testing, testers spoke with participants
about their sexuality, risk perceptions and sexual safety.
Once the results were available, participants learnt their
HIV status, as well as strategies to reduce sexual risk
taking.
Figure 1 ANRSeCOM’TEST Study diagram.
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Community-based HIV testing for MSMAIDES CBO staff members were trained speciﬁcally in
risk assessments, risk-reduction strategies and counsel-
ling using published motivational interview methods.
21
They were also trained in performing the rapid HIV test,
reading the test and delivering the result and referral for
conﬁrmatory test or other services if needed.
The VIKIA HIV1/2 BioMe ´rieux rapid HIV test kit
(sensitivity: 99.8%; speciﬁcity: 99.9%
22)w a su s e dt o
analyse a self-drawn whole blood sample from the partic-
ipant’s ﬁngertip. Results were available within 30 min.
Participants who tested positive were referred to HIV
clinics for conﬁrmatory blood tests and linkage to care.
The intervention offered HIV tests during 3 h sessions
once or twice a week in the evening and/or on the
weekend in the AIDES CBO locations in the French cities
of Montpellier, Lille, Bordeaux and Paris. No appoint-
ment was required, and HIV tests were performed on
a ﬁrst-come ﬁrst-served basis. We informed the MSM
community about the intervention through communi-
cation campaigns (posters, ﬂyers, web banners and ads)
at commercial and non-commercial gay venues, as well as
in gay websites, magazines and organisations. The study
sites were the settings of the AIDES CBO. The possibility
of performing an HIV test was, however, not advertised
outside the setting to preserve conﬁdentiality.
Study population
ANRSeCOM’TEST exclusively targeted MSM. Eligibility
for the study included age $18 years and pursuit of HIV
testing at one of the four participating AIDES CBO
locations. MSM who reported potential exposure #48 h
prior to enrolment were not included. Rather, they were
immediately referred to medical settings for HIV testing
and post-exposure prophylaxis.
One of the most important goals of the intervention
evaluated in this study was to target MSM who are not
regularly tested for HIV (or never tested). In the French
2004 Gay Press surveyda survey investigating lifestyle
and sexual behaviours in MSM who read the gay
pressd17% of MSM stated that they have never been
tested for HIV in their life. Among those with at least
a history of one HIV test, 27% stated that they were not
tested in the previous 2 years. Based on these results, we
therefore anticipated that 30% of MSM enrolled in our
study would not have a history of HIV testing in the
previous 2 years. We calculated the number of patients to
be enrolled in this study to have a precision of 4%
around this estimated point. The calculated sample size
was 504 MSM; given the highest number of participants
that could be tested by session in each centre, the
enrolment time was estimated at approximately 1 year.
Study outcomes
The population that has taken hold of the intervention
was described, in particular its demographic character-
istics, HIV testing habits and sexual practices.
The satisfaction of the participants with the
programme was collected just after the testing. The
difﬁculties occurred in handling rapid tests, the respect
of counselling and testing procedures and the propor-
tion of participants tested positive who were linked to
care were also assessed.
Data collection
Participants completed one questionnaire before and
one after the test. The pre-test questionnaire assessed
demographic characteristics, previous HIV testing
history, sexually transmitted infections (STIs) diagnosis
in the previous 6 months and sexual practices in the
previous 6 months. Using a 4-point Likert scale, the post-
test questionnaire assessed satisfaction with the testing
experience, that is, satisfaction globally and with each
step of counselling and testing procedure. It also
assessed satisfaction during the interviews with counsel-
lors, satisfaction with words used, items addressed and
information learnt. Finally, it addressed stress
and comfort of an HIV testing performed by peers in
non-medical settings.
Staff members used a form that outlined every step of
the intervention: welcome and description of the study,
participant’s signature of the consent form, major
concerns to address during pre- and post-test interviews
and difﬁculties faced at each step of HIV testing proce-
dure. For every participant, staff members marked the
completion of each step (done or addressed: yes/no/
partially) and mentioned any comments. This form was
in particular used to identify problems faced during
testing and counselling.
AIDES CBO staff members conducted face-to-face
interviews with patients who were tested positive
3 months later to evaluate their linkage to care.
Data analysis
The main analysis was descriptive: medians and IQR
were used to describe quantitative data, and numbers
and proportions were used to describe qualitative data.
Some comparisons were performed between partici-
pants tested negative and positive, and participants
retested during the study period at study sites and those
were not retested. For this purpose, the Fisher exact test
was used to compare proportions.
Statistical analyses were performed with SAS V.9.2
software (SAS Institute Inc.).
RESULTS
Overall, 598 men sought voluntary HIV testing at AIDES
CBO involving locations. We excluded 66 participants.
The three main reasons to not be included were (1)
reported sex exclusively with women (n¼25), (2) women
(n¼14) and (3) refused to participate due to the amount
of time they should have spent for testing and research
procedures (around 2 h, n¼10). Among the 17
remaining men not enrolled in the study, 10 refused for
different reasons (afraid of lack of conﬁdentiality, no
need to be tested for HIV, need time to think a possible
participation) and the seven other were excluded
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Community-based HIV testing for MSMbecause of age <18 years, a risk exposure <48 h or they
did not understand French speaking. The man who
reported a potential HIV exposure <48 h was referred to
a post-exposure prophylaxis service.
We enrolled 532 MSM in the study and performed 592
tests; 49 participants (9%) were tested two or more times
throughout the study period. More than half of the tests
were performed in Paris (285/592, 54%). Socio-demo-
graphic characteristics of participating men are shown in
table 1. Although 94% of men deﬁned themselves as
MSM, 128 (25%) stated that their sexual identity was
unknown to their family and 64 (13%) that they had not
revealed it to anyone.
Of the 527 MSM who answered questions regarding
their HIV testing habits, 368 (70%) reported having been
tested in the previous 2 years. Among these men, the
median number of tests in the previous 2 years was two
(IQR, 1e4) and the last test was performed for a median
of 8 months (IQR, 4e14) prior to enrolment (table 2).
Among the 159 MSM (30%) who had not been tested in
the previous 2 years, the last test was conducted for
a median of 46 months (IQR, 34e62) before enrolment.
Nearly all participants (96%) reported having had at
least one male partner in the previous 6 months; 92%
said that these were casual partners. The median
number of casual partners within the last 6 months was
12 (IQR, 6e25). Overall, 152 (35%) men reported
having unprotected anal intercourse with casual male
partners who were HIV infected or whose serostatus was
unknown. Among MSM who were tested in the previous
2 years, 100 (27%) had unprotected anal intercourse
with casual partners who were HIV infected or whose
serostatus was unknown (table 2). This proportion was
31% among participants who had not been tested in the
last 2 years. During the prior 6 months, 415 men (78%)
stated using at least once recreational drugs before or
during sex and 205 men (39%) reported regular use of
them. The recreational drugs the most used here were
alcohol (336; 65%), poppers (236; 46%) and cannabis
(140; 27%).
The most frequent reasons for participating in
ANRSeCOM’TEST and seeking HIV testing were (1)
reassurance (86%), (2) routine testing (42%) and (3)
recent risky sexual exposures (41%). Forty-nine men
(9%) returned to ANRSeCOM’TEST Study sites to be
retested. Of these, seven (14%) returned more than
twice. The median time between two tests among these
participants was 4 months (IQR, 2.5e6.7). MSM who
returned did not differ demographically from those who
came only once, but a larger proportion of returners had
tested for HIV within the previous 2 years (94% vs 68%,
p<0.0001).
Of the 532 participants, 15 (2.8%; 95% CI 1.4% to
4.2%) were tested positive (table 3). Among these, 12
(80%) received conﬁrmatory test results and linked to
care and three (20%) lost to follow-up. Their median
CD4 count at diagnosis was 550/mm
3 (IQR, 484e571).
Among the 15 men with positive results, eight (57%) had
not been tested for HIV in the previous 2 years (vs 30%
among HIV-negative men; p¼0.03).
We collected 514 post-test satisfaction questionnaires;
92% of participants who tested negative (464/504) and
70% of those who tested positive (7/10) reported being
‘very satisﬁed’ with the intervention. Three-quarter would
recommend ‘certainly’ community-based HIV testing and
counselling to a friend and 54% of those who tested
negative stated that they would choose ‘certainly’ the
same venue in the future. The main reasons for which
some patients were not ‘very satisﬁed’ (43; 8%) were the
amount of time spent at the testing facility (median, 2 h,
including a 45 min explanation of the study and ques-
tionnaires completion) and the hours during which
testing was available. Among the 440 MSM who had
reported to have performed HIV tests in the past, 55%
found community-based HIV testing less stressful than
traditional HIV testing, while only 5% found it more
stressful. Eight-eight per cent found that testing in non-
medical settings offers a best welfare. More than 98% of
participants attested they could address sexuality openly
with peers and no one reported feeling judged.
Table 1 Participant characteristics
Participant characteristics Median (IQR)
Age 31 (25e38)
Participant characteristics n (%*)
Sexual identity
Homosexual 432 (82)
Bisexual 66 (12)
Heterosexual or did not want
to deﬁne themselves
32 (6)
Homo/bisexual identity is
Accepted by everyone 140 (28)
Unknown to everyone 64 (13)
Unknown to familyy 128 (25)
Ever insulted because of sexuality 106 (20)
Matrimonial status
Single 367 (69)
In a free union with a man 124 (23)
Married or in a free union with a woman 26 (5)
Otherz 13 (3)
Educational level
Above high school 372 (71)
High school or below 155 (29)
Professional status
Employed 337 (64)
Unemployed 92 (17)
Student 99 (19)
Sex worker 16 (3)
*The study enrolled 532 men who have sex with men (MSM).
Percentages are calculated based on the number of respondents to
each question. For each question, there were less than ﬁve missing
data points (<1%); for questions regarding acceptance of
homosexuality and bisexuality, there were between 22 (4%) and 35
(7%) missing data points according to the question.
yParents and/or siblings.
zDivorced or separated from partner.
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Community-based HIV testing for MSMFrom the testers’ point of view, peers were satisﬁed
from their new activities. The different steps of the 592
testing and counselling procedures performed were
respected (more than 90% of completion for every step).
Difﬁculties in handling tests were rarely reported (<2%)
by testers, except concerning self-drawn blood samples
(19%) and blood collection by testers (14%). A second
test had to be performed for eight of the 592 tests
(1.5%) because an insufﬁcient amount of blood had
been collected. The results of each of these second tests
were negative. No other adverse or unexpected events
were reported. During pre-test counselling, major
concerns were not addressed rarely: risk perception in
4% of interviews, information about HIV transmission
routes in 7% and the anticipation of test results in 8%.
During post-test counselling, the test result was not
explained in 6% of cases, strategies for a better preven-
tion was not discussed in 8% and information about STIs
testing was not given in 10% of cases.
DISCUSSION
ANRSeCOM’TEST was an HIV testing programme that
targeted MSM and studied community-based HIV testing
using rapid HIV tests. Counselling and testing were
performed by community members who were not
healthcare workers. The programme reached MSM who
reported high rates of risky sexual behaviour known to
be risk factors of seroconversion for HIV.
23e25 Sexual
behaviours in this population is similar to that of MSM
who attend commercial gay venues in Paris in whom HIV
prevalence was estimated recently at 18%.
26
A substantial proportion of men enrolled in this study
had not been tested for HIV recently, even though
they were at high risk of HIV infection. These results may
suggest that community-based HIV testing programmes
may be attractive and convenient for population
groups that have not been reachable with traditional
HIV testing methods as it has been shown recently by
a community-based HIV testing programme in the UK.
17
The authors demonstrated that MSM at the community-
based programme were less likely to have been tested
previously compared with people who were seen at
genitourinary medicine clinics.
The programme also reached MSM regularly tested.
Moreover, although our study lasted only 12e17 months
according to the city, almost 10% of participating men
were tested twice or more. A community-based voluntary
counselling and testing programme for MSM in Geneva
has shown that the proportion of MSM who return for
testing is likely to increase over time.
15 The MSM who
returned for testing in the COM’TEST programme were
also tested signiﬁcantly more often for HIV than men
who came once. Increased availability and selection of
HIV testing services may therefore encourage even those
who already test regularly in traditional programmes to
test more often, thereby moving HIV diagnoses to earlier
in infection. In addition to community-based HIV
testing, other HIV testing strategies such as home tests or
tests available in pharmacies may also be interesting to
supplements pre-existing HIV testing services and
increases access to HIV testing in high-risk groups.
27 28
However, additional data are needed on beneﬁts and
harms of these strategies.
Table 2 Risk proﬁle of the 532 ANRSeCOM’TEST participants
HIV test in the previous 2 years?
No test ‡1 test
n[159 n[368
History of HIV testing in the previous 2 years*
Months since previous test, median (IQR) 46 (34e62) 8 (4e14)
Number of tests in the previous 2 years, median (IQR) 0 2 (1e4)
Casual male partners and sexual behaviour 6 months prior to testing, n (%) 132 (83) 333 (90)
Number of casual partners, median (IQR) 11 (5e20) 14 (6e30)
Partners were HIV infected or serostatus was unknown, n (%) 123 (77) 307 (83)
Number of casual partners who were HIV infected or whose serostatus was
unknown, median (IQR)
8( 3 e13) 10 (4e20)
Unprotected anal intercourse with partners who were HIV infected or whose
serostatus was unknowny, n (%)
50 (31) 100 (27)
History of STIs in the previous 2 years, n (%)z 8 (5) 44 (12)
Except for history of STIs in the previous 2 years, the differences between men who have sex with men tested or not tested for HIV in the
previous 2 years were not statistically signiﬁcant (p>0.05).
*Five missing data points (<1%).
yOverall, 152 men reported having unprotected anal intercourse with partners with HIV serostatus unknown or positive, but for two of them, the
information about the last test was missing.
zOne missing data point (<0.2%).
STI, sexually transmitted infection.
Table 3 Clinical characteristics of men who have sex with
men who tested positive for HIV
Positive rapid HIV test, n (%) 15 (2.8)
Loss to follow-up, n (%) 3 (20)
Conﬁrmation of positive
rapid HIV test, n (%)
12 (80)
Linkage to care, n (%) 12 (80)
CD4 count at diagnosis
(cells/mm
3), median (IQR)
550 (484e571)
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Community-based HIV testing for MSMCounselling and testing were performed by commu-
nity members who are considered as peers. Although
they were not healthcare workers, they were able to
handle tests correctly, deliver test results, refer men
according to their test result and respect counselling and
testing procedures along the whole study period. They
added testing and awareness of HIV serostatus to
comprehensive prevention counselling in line with
participants’ lives that is one of the added values in
comparison with HIV testing in the healthcare system.
The high rate of satisfaction in MSM who participated in
this study also shows that community-based HIV testing
and counselling was largely acceptable. Overall, partici-
pants reported feeling more comfortable with testing
and counselling with peers. The Barcelona Checkpoint
in Spain that is completely staffed by peers as
ANRSeCOM’TEST drawn the same conclusions.
20
Reasons for not being satisﬁed of the programme were
linked to the study part that was too long and imposed
tight opening sessions. The study part may curb some
men to come for testing; attendance may be higher in
the real life.
In France, the HIV prevalence was 1.6% among MSM
who attended voluntary counselling and testing clinics
29
and 2.2% in a community-based testing in Paris both run
by medical staff.
18 In our study, 2.8% of men tested
positive for HIV, and all those who underwent conﬁr-
matory testing were found to be HIV infected. The HIV
prevalence was high, and consistent with rates seen in
other recent community-based HIV testing programmes
in Europe. During the ﬁrst year of implementation,
these programmes found MSM prevalence rates
of 2.4% in Geneva, Switzerland,
15 3.2% in Brighton,
UK,
17 3.2% in Barcelona, Spain,
20 and 5.2% in
Amsterdam, the Netherlands.
14 These results suggest
again that community-based HIV testing programmes
like ANRSeCOM’TEST could reach MSM who are at
high risk of HIV infection. MSM with an HIV-positive test
have been tested less often in the previous 2 years than
men with a negative test; this result suggests that also this
programme could reach MSM at high risk who were not
tested recently in other testing services.
A large proportion of those men who tested positive
for HIV at AIDES CBO were referred and linked to care.
They were diagnosed at early stages of the disease, with
median CD4 counts of 550/mm
3dhigher than previ-
ously seen in traditional testing programmes. Data from
the French HIV surveillance system in 2009 demonstrate
that 20% of MSM were diagnosed with CD4 counts
<200/mm
3 and 62% had CD4 counts <500/mm
3.
2 4
These results are consistent with the British study, which
found a median CD4 count of 431/mm
3 among MSM
who were diagnosed in community-based programmes
compared with 311/mm
3 among those who were diag-
nosed in genitourinary medicine clinics.
17 When HIV
testing is performed by peers at CBOs, MSM who show
evidence of repeated risky sexual behaviour may feel less
judged than in a traditional HIV testing programme run
by healthcare workers. This difference in attitude may
lead MSM to check their serostatus more frequently and
sooner after exposure, resulting in earlier diagnoses.
This study has several limitations. First, ANRSe
COM’TEST was conducted in four French cities but
more than half of the participants enrolled in Paris.
Community-based HIV testing programmes may be
attractive and efﬁcient in large urban areas, but perhaps
less so in smaller cities, where an outreach approach may
work better. Second, we certainly underestimated the
proportion of MSM who would return for regular testing
at CBOs since the study duration was short and many
participants found the time spent completing question-
naires too lengthy. Third, the quality was assessed with
a form completed by the community staff. The comple-
tion rates of different steps of the testing and counsel-
ling procedure may be overestimated. Finally, the
number of HIV diagnoses was small. The prevalence
and median CD4 count among the few HIV-infected
participants should therefore be interpreted with
caution.
The ANRSeCOM’TEST Study was an HIV testing and
counselling programme exclusively based on MSM
community. It showed ﬁrst that this type of programme
could reach high-risk MSM, of whom a substantial
proportion had not been tested recently; second, peers
testers involved in such programmes may have the
capacity to perform the test into a comprehensive
prevention approach; third, participants tested positive
are at early stages of disease and that a high proportion
of them are linked to care. The programme demon-
strated that community-based HIV testing delivered by
non-medical staff could increase access to and choice of
HIV testing facilities, supplementing existing HIV testing
programmes. Based on this study results, French
ministry of health recently authorised community-based
HIV testing by non-healthcare CBO workers
30 as
a complementary HIV testing service in France.
Community-based HIV testing programmes should
also be assessed in other populations at high risk for
HIV infection and late presentation to care, such as
sub-Saharan African immigrants.
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